Therese Starr

1.6k total citations
23 papers, 746 citations indexed

About

Therese Starr is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Therese Starr has authored 23 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 8 papers in Molecular Medicine and 7 papers in Epidemiology. Recurrent topics in Therese Starr's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (8 papers) and Pneumonia and Respiratory Infections (6 papers). Therese Starr is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (8 papers) and Pneumonia and Respiratory Infections (6 papers). Therese Starr collaborates with scholars based in Australia, France and Hong Kong. Therese Starr's co-authors include Jeffrey Lipman, Jason A. Roberts, Janine Stuart, Melissa Lassig‐Smith, Steven C. Wallis, Paul Jarrett, Andrew Udy, David L. Paterson, Joel M. Dulhunty and Saurabh Pandey and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Therese Starr

21 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Therese Starr Australia	16	513	338	204	185	115	23	746
Melissa Lassig‐Smith Australia	14	446 0.9×	230 0.7×	169 0.8×	120 0.6×	87 0.8×	26	704
Janine Stuart Australia	18	453 0.9×	280 0.8×	169 0.8×	119 0.6×	126 1.1×	34	872
Thierry Seguin France	18	376 0.7×	341 1.0×	207 1.0×	123 0.7×	94 0.8×	38	847
Christina Scharf Germany	15	457 0.9×	317 0.9×	134 0.7×	129 0.7×	142 1.2×	54	795
Jeffrey J. Cies United States	18	604 1.2×	379 1.1×	207 1.0×	129 0.7×	131 1.1×	65	872
João Gonçalves-Pereira Portugal	15	422 0.8×	434 1.3×	189 0.9×	155 0.8×	85 0.7×	70	870
Janattul‐Ain Jamal Australia	10	511 1.0×	289 0.9×	198 1.0×	154 0.8×	64 0.6×	12	592
Stéphanie Ruiz France	18	324 0.6×	379 1.1×	135 0.7×	95 0.5×	129 1.1×	46	997
Uwe Liebchen Germany	15	407 0.8×	272 0.8×	124 0.6×	105 0.6×	128 1.1×	51	760
Isabelle Delattre Belgium	16	646 1.3×	394 1.2×	219 1.1×	207 1.1×	83 0.7×	21	1.0k

Countries citing papers authored by Therese Starr

Since Specialization

Citations

This map shows the geographic impact of Therese Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Therese Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Therese Starr more than expected).

Fields of papers citing papers by Therese Starr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Therese Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Therese Starr. The network helps show where Therese Starr may publish in the future.

Co-authorship network of co-authors of Therese Starr

This figure shows the co-authorship network connecting the top 25 collaborators of Therese Starr. A scholar is included among the top collaborators of Therese Starr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Therese Starr. Therese Starr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heffernan, Aaron J., Xin Liu, Suzanne L. Parker, et al.. (2025). Ceftriaxone population pharmacokinetics in plasma and cerebrospinal fluid of neurocritical care patients. International Journal of Antimicrobial Agents. 65(5). 107461–107461.

Lassig‐Smith, Melissa, et al.. (2024). Low-dose clonidine infusion to improve sleep in postoperative patients in the high-dependency unit. A randomised placebo-controlled single-centre trial. Intensive Care Medicine. 50(11). 1873–1883. 5 indexed citations

Heffernan, Aaron J., Menino Osbert Cotta, Steven C. Wallis, et al.. (2022). Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center Study. Antimicrobial Agents and Chemotherapy. 66(8). e0014222–e0014222. 7 indexed citations

Parker, Suzanne L., Steven C. Wallis, Cheryl Fourie, et al.. (2022). Evaluation of low-volume plasma sampling for the analysis of meropenem in clinical samples. Analytical and Bioanalytical Chemistry. 414(6). 2155–2162. 7 indexed citations

Sime, Fekade B., Melissa Lassig‐Smith, Therese Starr, et al.. (2020). Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain. Antimicrobial Agents and Chemotherapy. 65(1). 18 indexed citations

Lipman, Jeffrey, Stephen J. Brett, Jan J. De Waele, et al.. (2019). A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. Critical Care and Resuscitation. 21(1). 63–68. 35 indexed citations

Sime, Fekade B., Melissa Lassig‐Smith, Therese Starr, et al.. (2019). Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction. Antimicrobial Agents and Chemotherapy. 63(10). 44 indexed citations

Sime, Fekade B., Melissa Lassig‐Smith, Therese Starr, et al.. (2019). A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration. Antimicrobial Agents and Chemotherapy. 64(1). 27 indexed citations

Valero, Yarmarly C. Guerra, Jason A. Roberts, Jeffrey Lipman, et al.. (2019). Analysis of capillary microsamples obtained from a skin-prick to measure vancomycin concentrations as a valid alternative to conventional sampling: A bridging study. Journal of Pharmaceutical and Biomedical Analysis. 169. 288–292. 13 indexed citations

10.

Sime, Fekade B., Janine Stuart, Therese Starr, et al.. (2018). A pharmacokinetic case study of intravenous posaconazole in a critically ill patient with hypoalbuminaemia receiving continuous venovenous haemodiafiltration. International Journal of Antimicrobial Agents. 52(4). 506–509. 7 indexed citations

11.

Sime, Fekade B., Janine Stuart, Therese Starr, et al.. (2018). Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 62(6). 20 indexed citations

12.

Alobaid, Abdulaziz S., Steven C. Wallis, Paul Jarrett, et al.. (2017). Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 61(3). 63 indexed citations

13.

Bandeshe, Hiran, Robert Boots, Joel M. Dulhunty, et al.. (2016). Is inhaled prophylactic heparin useful for prevention and Management of Pneumonia in ventilated ICU patients?. Journal of Critical Care. 34. 95–102. 19 indexed citations

14.

Alobaid, Abdulaziz S., Steven C. Wallis, Paul Jarrett, et al.. (2016). Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 60(8). 4577–4584. 42 indexed citations

15.

Udy, Andrew, Paul Jarrett, Melissa Lassig‐Smith, et al.. (2016). Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance. Journal of Neurotrauma. 34(1). 137–144. 52 indexed citations

16.

Cohen, Jeremy, Carel Pretorius, Jacobus Ungerer, et al.. (2016). Glucocorticoid Sensitivity Is Highly Variable in Critically Ill Patients With Septic Shock and Is Associated With Disease Severity*. Critical Care Medicine. 44(6). 1034–1041. 37 indexed citations

17.

Dulhunty, Joel M., Jason A. Roberts, Joshua S. Davis, et al.. (2015). A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. American Journal of Respiratory and Critical Care Medicine. 192(11). 1298–1305. 167 indexed citations

18.

Udy, Andrew, Paul Jarrett, Janine Stuart, et al.. (2014). Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds. Critical Care. 18(6). 657–657. 59 indexed citations

19.

Dulhunty, Joel M., Jason A. Roberts, Joshua S. Davis, et al.. (2013). A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study. Critical Care and Resuscitation. 15(3). 179–185. 15 indexed citations

20.

Udy, Andrew, Paul Jarrett, Melissa Lassig‐Smith, et al.. (2013). A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations. BMC Nephrology. 14(1). 250–250. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact